Sargent Investment Group’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-349
Closed -$3K 185
2020
Q3
$3K Sell
349
-636
-65% -$5.47K ﹤0.01% 160
2020
Q2
$25K Hold
985
0.01% 147
2020
Q1
$18K Sell
985
-324
-25% -$5.92K 0.01% 136
2019
Q4
$154K Buy
+1,309
New +$154K 0.06% 148